The leaders of the NIHR ARC East Midlands demonstrated how UK researchers are working nationally and globally to tackle major health challenges and improve outcomes in the UK and internationally ...
A grieving father who vowed to prevent other families suffering the same heartbreak has secured ‘life-saving’ changes to the way Type 1 diabetes is identified in children across England, ...
NICE has issued final draft guidance recommending teplizumab for NHS reimbursement, positioning the drug as the UK’s first immunotherapy for delaying the onset of stage 3 type 1 diabetes in ...
A major conference which has a new direction to advance collaboration across cardiovascular, renal and metabolic care has announced the first experts joining its speaker line-up for 2026. Dr ...
Hypo Awareness Week 2026 has been funded by Roche, which has had no input into the campaign’s arrangements or content. We anticipate that the campaign will receive further sponsorship from ...
Professor Wasim Hanif, Professor of Diabetes and Endocrinology at University Hospitals Birmingham (UHB), has been awarded an OBE in the King’s Birthday Honours List. Professor Hanif, who ...
A new tool designed to help healthcare professionals recognise and avoid language that can contribute to diabetes stigma during healthcare appointments has been published. Based on NHS Language ...
People in the UK could soon have access to a pill version of Wegovy after regulators approved the medication for prescription use, making it the first oral GLP-1 weight-loss treatment of its kind ...
The importance of having a blood glucose monitor (BGM) alongside a continuous glucose monitor (CGM) was highlighted by a diabetes specialist dietitian in a recent online interview for the ...
A forward-thinking technology company in Wales developing the world’s first non-invasive wearable blood glucose monitor has been recognised at a national level for its contribution to advancing ...